Clinical trial
SPO2 NEXT GEN VALIDATION STUDY - PHILIPS OPTIMUS
NCT07521735 is registered in ClinicalTrials.gov with Philips Clinical & Medical Affairs Global as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SPO2 NEXT GEN VALIDATION STUDY - PHILIPS OPTIMUS
- Lead sponsor
- Philips Clinical & Medical Affairs Global
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 9, 2026
- Completion date
- March 31, 2026
- Enrollment
- 46 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pulse oximetry